5 May, 2023
CLS Americas and Unio Health Partners Announce Clinical Study
We are happy to share that CLS Americas has entered into an agreement with Genesis Research, LLC, an affiliate of Unio Health Partners, to conduct a Phase I clinical study titled, “Micro Ultra-Sound Guided, Transperineal Focal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.”
Read more
13 April, 2023
CLS Americas Announces Research Collaboration with the National Institutes of Health Clinical Center
Under the agreement, NIHCC will access the clinical utility of the CLS’s TRANBERG® Thermal Therapy System towards MRI/Ultrasound fusion-guided focal laser ablation (FLA) of prostate tissue and prostate cancer in male patients.
Read more
21 March, 2023
NEW: Animation showing Fusion-guided Focal Laser Ablation in Prostate Cancer
We are proud to release a detailed video animation of the minimally invasive, fusion-guided, focal laser ablation (FLA) of a prostate tumor using the TRANBERG™ Thermal Therapy System.
Read more